Goldman Sachs Group Inc Ars Pharmaceuticals, Inc. Comm Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,325,739 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,325,739
Previous 1,464,312
9.46%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions